Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
about
Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c releaseEvidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of PremarinPharmacology of estrogens and progestogens: influence of different routes of administrationEffects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective StudyGlutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogensEffects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in miceTissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combinationA component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.Formulations of hormone therapy and risk of Parkinson's disease.Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.Estrogens and cognition: Friends or foes?: An evaluation of the opposing effects of estrogens on learning and memory.Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.Estradiol and cognitive function: past, present and future.Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal modelsShort-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals.Quality of life among post-menopausal women due to oxidative stress boosted by dysthymia and anxietyContribution of estrogen receptor subtypes, ERα, ERβ, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice.Beneficial effects of melatonin in experimental models of Alzheimer disease.Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.A prototypical Sigma-1 receptor antagonist protects against brain ischemia.Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.Modulation of NR1 subunit of N-methyl-D-aspartate receptor by ovariectomy and passive avoidance learningDonepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis.Premarin improves memory, prevents scopolamine-induced amnesia and increases number of basal forebrain choline acetyltransferase positive cells in middle-aged surgically menopausal ratsPotential role of estrogen in the pathobiology and prevention of Alzheimer's disease.Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.The effects of oestrogens and their receptors on cardiometabolic health.Young coconut juice, a potential therapeutic agent that could significantly reduce some pathologies associated with Alzheimer's disease: novel findings.Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women.East meets West: an herbal tea finds a receptor.Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation.Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat.Celecoxib affects estrogen sulfonation catalyzed by several human hepatic sulfotransferases, but does not stimulate 17-sulfonation in rat liver.
P2860
Q24806246-948AE414-850E-4184-863E-B4B7293EE054Q24812462-C520FC91-F793-4630-ADE3-C102F7760DB5Q27648855-4AD1DD95-7F64-4F7D-8345-18237DFE62FFQ28268346-67762611-F502-4598-B6F8-2B9855DCB207Q28547748-759AD0B4-E9BB-4E08-A12E-A353E6163F14Q28575769-AB4370D1-A1F3-472B-8007-B4AF71456139Q30353161-8B1665D4-5E55-4035-A35C-1B1F4BC02BCDQ30454254-4FE7FCEA-105F-4643-A3DA-A32478523BB5Q33642558-808B2D05-348A-4434-B33A-E7B36BD952D6Q34316221-B2EDEBD0-824D-42C0-8585-CC6EAB6D3A42Q34437648-937CF700-B504-4C7E-9BDB-787F377DAD4BQ34468841-1177C906-A917-425D-BF5A-5B1616E5D338Q34483748-56D6CAC8-3F1C-496B-8334-5EA214BA7662Q34712250-F447FF40-9E16-4567-B6CF-DA7FEB3CFF9FQ35054370-D2656B87-C8CA-4E58-A66A-481C2E198E2DQ35078498-C18E7E82-BEB5-4349-9AD8-10BF6AD7C3AAQ35826373-C0A0A697-4715-4382-BE42-08DB15039172Q35871967-045FFD5C-D587-4A16-A8E8-6A1203FBD31EQ36238906-774D6AE4-0C3F-46F9-89DD-9918F95190BEQ36279808-88CD9F72-BC9D-4F6E-B9DC-52424F1BB1B2Q36367936-50F18C9E-DEBA-416C-B736-0F2F66386E08Q36576477-569BBA28-FBEF-41D4-A22E-CA3383521D46Q36909572-678EAFBF-DE72-4B69-BD66-0E78DCCCB635Q36976939-7F92153B-23D2-466F-A245-4F01A0D0FFCBQ37063691-3E238C87-23E9-4942-B825-D526D7D799F7Q37084906-3C5E746F-58FA-4504-B15F-CE29103802C7Q37221035-AEF617E9-A990-4B30-9B0F-71B4ACFB044FQ37311685-8E5F7F02-2D8F-4685-8204-FF8110918474Q37332321-982E7FD9-A1B1-41A7-8668-3689F067B0DFQ37417828-769A82CB-D28F-4212-AA56-BDA432942DCDQ37418919-015C633C-1383-40EC-BBA9-5C7F4EF86F3BQ37442901-1A90EAA0-F04B-4BD1-8F27-E0537FABD898Q38739583-06E0EDA7-5284-45E2-A129-44E2D202C2E1Q38901474-F01DC5DE-7BBB-4555-863C-43373E1BB1F7Q39812159-1C493FC0-D67F-4DA7-8352-10DD7F0531EDQ40238961-E1B336DF-1A15-4A20-B513-B65D102EB726Q40364716-A1C7B3EE-2FF1-41A9-968B-103577E72173Q44352080-9E7E99DE-EEAD-4D96-83F7-9F9D13F2061EQ45250159-8870B96A-822F-4B6A-8081-4077615CDA5DQ46359743-8E7FF1D2-A0C6-4EA5-9C49-FD7451860E78
P2860
Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@ast
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@en
type
label
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@ast
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@en
prefLabel
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@ast
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@en
P1476
Estrogens and menopause: pharm ...... diseases such as Alzheimer's.
@en
P2093
Bhagu R Bhavnani
P304
P356
10.1016/S0960-0760(03)00220-6
P577
2003-06-01T00:00:00Z